The primary considerations and image guided diagnosis of an infected urachal cyst in a pediatric patient

Daniel Novick1, Brett Heller1, Dahua Zhou1

  • 1Nassau University Medical Center, Department of Radiology, 2201 Hempstead Turnpike, East Meadow, NY 11554, USA.

Radiology Case Reports
|August 3, 2019
PubMed

Insights

Urachal cysts are rare, often asymptomatic remnants of the allantois. Infection can cause symptoms mimicking other conditions, delaying diagnosis and requiring surgical treatment.

Area of Science:

  • Urology
  • Embryology
  • Radiology

Background:

  • Urachal cysts arise from the embryological remnant of the allantois, connecting the fetal bladder to the umbilicus.
  • These cysts are rare, occurring in 1 in 5000 live births but clinically relevant in only 1 in 150,000 individuals.

Observation:

  • Urachal cysts are typically asymptomatic until infection occurs.
  • Infected cysts can present with diverse symptoms, including umbilical discharge in children and hematuria in adults, often leading to misdiagnosis.
  • Imaging modalities like ultrasound and CT are crucial for diagnosis, revealing characteristic findings such as increased echogenicity or thick-walled cystic structures.

Findings:

  • Infection is the primary cause of symptomatic urachal cysts.
  • Diagnostic delays are common due to the varied and non-specific presentation of infected urachal cysts.
  • Imaging findings on ultrasound and CT are key to identifying urachal remnant diseases.

Implications:

  • Prompt diagnosis and treatment of infected urachal cysts are essential to prevent complications.
  • Surgical drainage and excision of the urachal remnant offer definitive treatment.
  • Increased awareness among clinicians can improve diagnostic accuracy for this rare condition.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
263
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
196
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
257
Nursing Process for Patient and Caregiver Teaching I: Assessment and Diagnosis01:24

Nursing Process for Patient and Caregiver Teaching I: Assessment and Diagnosis

The nursing process provides a clinical decision-making framework for patients and families to establish and implement a personalized care plan. Since part of the nurse's duties is to teach patients, the steps of the nursing process are the most effective way to approach instruction. The nursing process and the teaching-learning process are inextricably linked.
It is critical to determine the patient's learning needs during the assessment. Determination of learning needs compounds data...
2.4K
Design Consideration01:22

Design Consideration

Designing a structure involves a series of considerations, primarily the material's ultimate strength, calculated through tests that measure changes under increased force until the material reaches its breaking point or limit. The ultimate load, where the material breaks, is divided by its original cross-sectional area, resulting in the ultimate normal stress or strength. The ultimate shearing stress is another significant factor taken into account.
The factor of safety is another key...
557